was featured on the cover page of September 2015 issue of Forbes India and our Company was recognized as one of the 13 hidden gems of India in that issue. During the last 23 years he has worked in various pharmaceutical companies including Ranbaxy Laboratories Limited, Vera Laboratories Limited and Vorin
10.30 AM Dec 6th 2016
17.5 billion yen a year earlier. Daiichi Sankyo still expects full-year profit of 50 billion yen, the Tokyo-based drugmaker said in a statement today. Daiichi Sankyo, which owns 64 percent stake of India’s Ranbaxy Laboratories Ltd. (RBXY), accounts for the Indian unit’s earnings with a quarter lag
10.24 AM Jan 31st 2013
, from 17.5 billion yen a year earlier. Daiichi Sankyo still expects full-year profit of 50 billion yen, the Tokyo-based drugmaker said in a statement today. Daiichi Sankyo, which owns 64 percent stake of India’s Ranbaxy Laboratories Ltd. (RBXY), accounts for the Indian unit’s earnings with a quarter
10.23 AM Jan 31st 2013
Ranbaxy Laboratories has informed BSE that a meeting of the Board of Directors of the Company will be held on February 26, 2013, inter alia, to consider and approve Audited Financial Results for the quarter and financial year ended December 31, 2012.
5.05 PM Jan 29th 2013
into a Confidentiality Agreement with M/s. Ranbaxy Laboratories Ltd to discuss business alliance. 13 Apr 2007 Jupiter Bioscience - Outcome of Board Meeting Jupiter Bioscience Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 12, 2007, inter alia, has decided
6.32 PM Jan 17th 2013
Source:Economic Times - In a chat with ET Now, Deepak Mohoni, Director, trendwatchindia.com, shares his views on Ranbaxy Laboratories Ltd. ET Now: What is your call on Ranbaxy Laboratories Ltd? Deepak Mohoni: Sell Ranbaxy Labs at a stop loss of Rs 494 and a target of 478. It is a pure day trade.
4.28 PM Jan 17th 2013
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.